cyc 202 has been researched along with 1-NA-PP1 in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (1-NA-PP1) | Trials (1-NA-PP1) | Recent Studies (post-2010) (1-NA-PP1) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 11 | 0 | 6 |
| Protein | Taxonomy | cyc 202 (IC50) | 1-NA-PP1 (IC50) |
|---|---|---|---|
| Phospholipase D2 | Homo sapiens (human) | 0.387 | |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.12 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.3035 | |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | 0.34 | |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.66 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.6 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.015 | |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | 1.97 | |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | 0.445 | |
| Casein kinase I isoform delta | Homo sapiens (human) | 0.15 | |
| Protein kinase C epsilon type | Homo sapiens (human) | 0.021 | |
| Phospholipase D1 | Homo sapiens (human) | 0.387 | |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | 0.9 | |
| Phospholipase D | Streptomyces chromofuscus | 0.065 | |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
2 other study(ies) available for cyc 202 and 1-NA-PP1
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |